Get In Touch
Tmapril cpver 104x80.jpg
Current Issue

animation-neutral-tts-300x100' width='300' height='100' border='0

Tata Motors, Tata Motors Finance Group enter into a partnership with Kool-ex Cold Chain

By Swati Deshpande,

Added 15 February 2019

To supply and funds 200 Fully Built Reefer Trucks

Tie up includes manufacturing of the specially built pharma compliant reefer trucks

Developing a unique one stop solution for Kool-ex Cold Chain Ltd, this tie up includes manufacturing of the specially built pharma compliant reefer trucks which will be covered under the Tata Sampoorna Seva umbrella of value added services and a complete funding plan by TMF Group with a mixture of Equity and Debt, making the entire transaction a single window structure. The reefer units used for this deal will be built on the popular Tata LPT 1613 MCV trucks and the Tata LPT 2518 Multi axle truck.

According to Shyam Mani, Manging Director, Tata Motors Finance Group - "We are elated to be a part of this one of a kind tie up to provide complete financing solutions to Kool-ex Cold Chain Limited. As a part of this tie up, we will not only be providing vehicle financing through Tata Motors Finance Limited (TMFL) but will also provide mezzanine equity financing to the company through Tata Motors Finance Solutions Limited (TMFSL), making this a structured financing deal. We are confident that this complete package will deliver the best for all companies who are a part the deal and will lay a strong foundation for a continued association ahead."

On this occasion, R T Wasan, Head, Marketing & Sales, CVBU, Tata Motors said, "Tata Motors as the leading CV player in the Industry continues to work closely with its customers and their clients to develop total solutions for their transportation and logistics requirements. With a sectoral approach, Tata Motors has worked with Kool-Ex to co-develop the fully built reefer unit to meet the sophisticated logistics requirements of the Pharma Industry which will meet the rapidly growing needs of the Pharma Industry due to the anticipated changes in the regulations related to transportation and storage"

 

END

comments powered by Disqus